Toward a More Proactive Health Care System
Dr. Alexandra Bause explains how today’s reactive approach provides sick care, not health care—and how biopharma strives to change that.
Dr. Alexandra Bause explains how today’s reactive approach provides sick care, not health care—and how biopharma strives to change that.
BCG’s new annual report identifies the modalities that are progressing most rapidly and those that hold the greatest promise for patient outcomes and company revenues.
Biopharma companies can promote the success of product launches by initiating cross-functional collaboration on evidence generation early in the development process.
The Team B approach involves assembling an independent cross-functional team to conduct rapid reviews of launch plans and market conditions for new pharmaceutical products.
Biopharma and medtech companies that adopt a digital-native approach can generate better outcomes, lower costs, and greater customer satisfaction.
Hudson discusses the company’s commitment to reaching net zero emissions by 2045.
Francis discusses the role that Teva’s people are playing in the execution of the company’s new growth strategy.
Chief Commercial Officer Everett Cunningham describes Exact Sciences’ efforts to boost awareness of this deadly disease.
A suite of improvement levers provides the basis for designing a health care payers’ customized productivity transformation.
A use case-based approach can help overcome the sometimes formidable barriers to digitizing care and the other aspects of hospital operations.
Lessons learned during COVID-19 present an opportunity to improve the US public health system. Expanding practitioners’ capacities in decision-making, communication, and working with data is a critical step.
The finances of the US health system are weak. If systemic issues are not resolved, the situation will worsen, with detrimental consequences for patient care and care equity.
Medtech management teams face an unfamiliar list of questions. The players that can successfully navigate the challenging terrain will be the winners of the 2020s.
The technology has a range of uses in medtech, and the main challenge is knowing how and where to start. Here are 60 ways to generate quick wins.
Medical technology companies play a big part in health care’s carbon emissions problem, both at the patient and provider levels. Fortunately, these firms can reduce their footprint affordably.
A sea change is underway in how companies win regulatory approval for new health care products—particularly in the use of digital technology—and which markets they prioritize.
The biopharma industry faces demands for more action to address health inequities. We provide a guide and tools to help companies integrate equity across the product lifecycle.
COVID-19 offered valuable lessons in combating epidemic-level disease. Four measures can help institutionalize what we’ve learned.
What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?
Experts across BCG and BCG X talk about the trends and opportunities that lie ahead for the digital health care market.